title: Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease.
abstract: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopamine neurons of the nigrostriatal system, resulting in severe motor disturbances. Although much less appreciated, non-motor symptoms are also very common in PD and many can be traced to serotonin neuronal deficits. Tryptophan hydroxylase (TPH) 2, the rate-limiting enzyme in the serotonin biosynthesis, is a phenotypic marker for serotonin neurons and is known to be extremely labile to oxidation. Therefore, the oxidative processes that prevail in PD could cause TPH2 misfolding and modify serotonin neuronal function much as is seen in dopamine neurons. Oxidation of TPH2 inhibits enzyme activity and leads to the formation of high molecular weight aggregates in a dithiothreitol-reversible manner. Cysteine-scanning mutagenesis shows that as long as a single cysteine residue (out of a total of 13 per monomer) remains in TPH2, it cross-links upon oxidation and only cysteine-less mutants are resistant to this effect. The effects of oxidants on TPH2 catalytic function and cross-linking are also observed in intact TPH2-expressing HEK293 cells. Oxidation shifts TPH2 from the soluble compartment into membrane fractions and large inclusion bodies. Sequential non-reducing/reducing 2-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting confirmed that TPH2 was one of a small number of cytosolic proteins that form disulfide-bonded aggregates. The propensity of TPH2 to misfold upon oxidation of its cysteine residues is responsible for its catalytic lability and may be related to loss of serotonin neuronal function in PD and the emergence of non-motor (psychiatric) symptoms.
authors.affiliation: Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA. donald.kuhn@wayne.edu
authors.forename: Donald M
authors.initials: DM
authors.lastname: Kuhn
authors.forename: Catherine E
authors.initials: CE
authors.lastname: Sykes
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Geddes
authors.forename: Karen L Eskow
authors.initials: KL
authors.lastname: Jaunarajs
authors.forename: Christopher
authors.initials: C
authors.lastname: Bishop
mesh_terms: D001921:Brain / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D020134:Catalytic Domain / Q000235:genetics; D003432:Cross-Linking Reagents / Q000737:chemistry / Q000378:metabolism; D003545:Cysteine / Q000378:metabolism; D003704:Dementia / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D004220:Disulfides / Q000737:chemistry / Q000378:metabolism*; D057809:HEK293 Cells; D006801:Humans; D009474:Neurons / Q000201:enzymology; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000235:genetics*; D010300:Parkinson Disease / Q000175:diagnosis / Q000201:enzymology* / Q000235:genetics; D011485:Protein Binding / Q000235:genetics; D017510:Protein Folding; D012701:Serotonin / Q000096:biosynthesis* / Q000172:deficiency* / Q000502:physiology; D014365:Tryptophan Hydroxylase / Q000737:chemistry / Q000378:metabolism*
chemical_list: D003432:Cross-Linking Reagents; D004220:Disulfides; D012701:Serotonin; C494784:TPH2 protein, human; D014365:Tryptophan Hydroxylase; D003545:Cysteine